|
FY2026
12 months to Mar 31, 2026
|
FY2025
12 months to Mar 31, 2025
|
FY2024
12 months to Mar 31, 2024
|
FY2023
12 months to Mar 31, 2023
|
FY2022
12 months to Mar 31, 2022
|
|
|---|---|---|---|---|---|
| Net sales | |||||
| Cost of sales | |||||
| Gross profit | |||||
| Research and development | |||||
| Selling, general and administrative | |||||
| Amortization of acquired intangible assets | |||||
| Special charges (income) and other, net | |||||
| Operating expenses | |||||
| Operating income | |||||
| Interest income | |||||
| Interest expense | |||||
| Loss on settlement of debt | |||||
| Other loss, net | |||||
| Income before income taxes | |||||
| Income tax provision | |||||
| Net income (loss) | |||||
| Dividends on Series A Preferred Stock | |||||
| Net income (loss) attributable to common stockholders | |||||
| Basic net income (loss) per common share (in dollars per share) | |||||
| Diluted net income (loss) per common share (in dollars per share) | |||||
| Dividends declared per common share (in dollars per share) | |||||
| Basic common shares outstanding (in shares) | |||||
| Diluted common shares outstanding (in shares) |
Loading...
